These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

685 related articles for article (PubMed ID: 33437907)

  • 41. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.
    Yang WS; Va P; Bray F; Gao S; Gao J; Li HL; Xiang YB
    PLoS One; 2011; 6(12):e27326. PubMed ID: 22205924
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systematic Review and Meta-analysis: Association of Aspirin With Incidence of Hepatocellular Carcinoma.
    Zhou X; Zhang T; Sun Y; Li C; Ding X; Zhu Y; Li L; Fan Z
    Front Pharmacol; 2022; 13():764854. PubMed ID: 35300300
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of low-dose aspirin administration on long-term survival of cirrhotic patients after splenectomy: A retrospective single-center study.
    Du ZQ; Zhao JZ; Dong J; Bi JB; Ren YF; Zhang J; Khalid B; Wu Z; Lv Y; Zhang XF; Wu RQ
    World J Gastroenterol; 2019 Jul; 25(28):3798-3807. PubMed ID: 31391774
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence and Determinants of Hepatocellular Carcinoma in Autoimmune Hepatitis: A Systematic Review and Meta-analysis.
    Tansel A; Katz LH; El-Serag HB; Thrift AP; Parepally M; Shakhatreh MH; Kanwal F
    Clin Gastroenterol Hepatol; 2017 Aug; 15(8):1207-1217.e4. PubMed ID: 28215616
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Aspirin and the risk of colorectal and other digestive tract cancers: an updated meta-analysis through 2019.
    Bosetti C; Santucci C; Gallus S; Martinetti M; La Vecchia C
    Ann Oncol; 2020 May; 31(5):558-568. PubMed ID: 32272209
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association between daily aspirin therapy and risk of hepatocellular carcinoma according to metabolic risk factor burden in non-cirrhotic patients with chronic hepatitis B.
    Lee CH; Lee YB; Moon H; Chung JW; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Aliment Pharmacol Ther; 2023 Oct; 58(7):704-714. PubMed ID: 37461332
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study.
    Yun B; Ahn SH; Yoon JH; Kim BK
    Am J Gastroenterol; 2022 May; 117(5):758-768. PubMed ID: 35294425
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Sex and regional disparities in incidence of hepatocellular carcinoma in autoimmune hepatitis: a systematic review and meta-analysis.
    Yan LJ; Yao SY; Meng GX; Liu KX; Li HC; Ding ZN; Dong ZR; Hong JG; Chen ZQ; Li T
    Hepatol Int; 2021 Dec; 15(6):1413-1420. PubMed ID: 34478116
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The relationship between aspirin consumption and hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang S; Zuo L; Lin Z; Yang Z; Chen R; Xu Y
    Eur J Med Res; 2023 Jul; 28(1):226. PubMed ID: 37422691
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis.
    Tseng CH; Hsu YC; Chen TH; Ji F; Chen IS; Tsai YN; Hai H; Thuy LTT; Hosaka T; Sezaki H; Borghi JA; Cheung R; Enomoto M; Nguyen MH
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1039-1052. PubMed ID: 33007228
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The occurrence of hepatocellular carcinoma in different risk stratifications of clinically noncirrhotic nonalcoholic fatty liver disease.
    Lee TY; Wu JC; Yu SH; Lin JT; Wu MS; Wu CY
    Int J Cancer; 2017 Oct; 141(7):1307-1314. PubMed ID: 28509327
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatocellular Carcinoma Incidence in Alcohol-Associated Cirrhosis: Systematic Review and Meta-analysis.
    Huang DQ; Tan DJH; Ng CH; Amangurbanova M; Sutter N; Lin Tay PW; Lim WH; Yong JN; Tang A; Syn N; Muthiah MD; Tan EXX; Dave S; Tay B; Majzoub AM; Gerberi D; Kim BK; Loomba R
    Clin Gastroenterol Hepatol; 2023 May; 21(5):1169-1177. PubMed ID: 35940513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of hepatocellular carcinoma in antiviral treatment-naïve chronic hepatitis B patients treated with entecavir or tenofovir disoproxil fumarate: a network meta-analysis.
    Huang ZH; Lu GY; Qiu LX; Zhong GH; Huang Y; Yao XM; Liu XH; Huang SJ; Wu T; Yuan Q; Wang YB; Su YY; Zhang J; Xia NS
    BMC Cancer; 2022 Mar; 22(1):287. PubMed ID: 35300634
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative Effectiveness of Entecavir Versus Tenofovir for Preventing Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: A Systematic Review and Meta-Analysis.
    Dave S; Park S; Murad MH; Barnard A; Prokop L; Adams LA; Singh S; Loomba R
    Hepatology; 2021 Jan; 73(1):68-78. PubMed ID: 32277491
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
    Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
    J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aspirin use and risk of hepatocellular carcinoma in patients with chronic hepatitis B with or without cirrhosis.
    Jang H; Lee YB; Moon H; Chung JW; Nam JY; Cho EJ; Lee JH; Yu SJ; Kim YJ; Lee J; Yoon JH
    Hepatology; 2022 Aug; 76(2):492-501. PubMed ID: 35100447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Aspirin in Patients with Viral Hepatitis: Systematic Review and Meta-Analysis of Observational Studies.
    Bian W; Bian W; Li Q; Li Y
    J Gastrointest Cancer; 2024 Jun; 55(2):638-651. PubMed ID: 38557825
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: an individual patient data meta-analysis.
    Sapena V; Enea M; Torres F; Celsa C; Rios J; Rizzo GEM; Nahon P; Mariño Z; Tateishi R; Minami T; Sangiovanni A; Forns X; Toyoda H; Brillanti S; Conti F; Degasperi E; Yu ML; Tsai PC; Jean K; El Kassas M; Shousha HI; Omar A; Zavaglia C; Nagata H; Nakagawa M; Asahina Y; Singal AG; Murphy C; Kohla M; Masetti C; Dufour JF; Merchante N; Cavalletto L; Chemello LL; Pol S; Crespo J; Calleja JL; Villani R; Serviddio G; Zanetto A; Shalaby S; Russo FP; Bielen R; Trevisani F; Cammà C; Bruix J; Cabibbo G; Reig M
    Gut; 2022 Mar; 71(3):593-604. PubMed ID: 33741640
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.